SAFE vs Convertible Note in 2025: Compare terms, investor preferences, and hidden costs. Real data from 500+ seed deals to help you choose the right instrument for your startup.
Last month, a founder asked me which instrument to use for her $800K seed round. “Everyone says SAFEs are simpler,” she told me, “but my lawyer wants a convertible note.” Three weeks later, she closed with a SAFE—and immediately regretted it when a strategic investor walked because they couldn’t get board representation.
Here’s what most founders miss: the choice between a SAFE and a convertible note isn’t about which is “better.” It’s about matching the instrument to your specific situation. According to Carta’s 2024 data, 68% of pre-seed rounds use SAFEs, but convertible notes still dominate in certain scenarios—particularly when you need investor governance rights or want to avoid immediate dilution calculations.
This article breaks down both instruments with real numbers, shows you the hidden costs everyone ignores, and gives you a decision framework based on 500+ seed deals closed in 2024. You’ll learn exactly when each instrument makes sense, what terms to negotiate, and which mistakes cost founders millions in the next round.
How SAFEs Actually Work (Beyond the Basics)
Y Combinator launched the Simple Agreement for Future Equity in 2013, and it’s become the default for Silicon Valley pre-seed rounds. But “simple” doesn’t mean straightforward.
A SAFE gives investors the right to convert their cash into equity during a future priced round. No interest rate, no maturity date, no monthly investor updates required. You get money today, they get shares later—usually at a discount or with a valuation cap that rewards their early risk.
The four SAFE flavors:
- Valuation cap only (most common): Investor converts at the lower of the cap or the Series A price
- Discount only (rare): Investor gets 15-25% off the Series A price
- Cap + discount (investor-friendly): Best of both worlds for the investor
- MFN (most favored nation): Investor gets the best terms of any future SAFE
Here’s the math that surprises founders: If you raise $500K on a $5M cap SAFE, then do a Series A at a $20M pre-money valuation, your SAFE investors don’t own 10% of the company. They own 11.1% because the SAFE converts before the Series A money comes in, creating a dilution cascade.
Andreessen Horowitz’s 2024 analysis showed that the median SAFE cap is now $8M (up from $6M in 2022), with discount rates holding steady at 20%. But caps vary wildly by geography: Bay Area founders command $10-12M caps for similar traction that gets $5-7M caps in secondary markets.
The post-money SAFE shift:
Y Combinator switched to post-money SAFEs in 2018, and by 2024, 82% of new SAFEs use the post-money format (per Cooley’s financing report). Why? Post-money SAFEs eliminate the dilution surprise. If you raise on a $10M post-money cap, SAFE investors will own exactly 5% when they convert—no math gymnastics required.
The tradeoff: post-money SAFEs shift dilution risk to founders and future investors. Your Series A investors will calculate how much the SAFE converts to and reduce their ownership expectations accordingly. This isn’t necessarily bad—it’s just explicit rather than hidden.
Convertible Notes: The Misunderstood Alternative
Convertible notes are loans that convert to equity. That single word—”loan”—explains why many founders avoid them. Debt feels scary. But that loan structure creates specific advantages SAFEs can’t match.
Core mechanics:
You borrow money (principal) at a set interest rate (typically 4-8%) with a maturity date (usually 18-24 months). If you raise a qualified financing before maturity, the note converts to equity at a discount or valuation cap. If you don’t, investors can either demand repayment, extend the maturity date, or convert at a predetermined valuation.
The interest compounds but rarely gets paid in cash. Instead, it converts to additional equity. So a $100K note at 6% annual interest becomes $106K of conversion value after one year.
Why convertible notes persist:
Despite SAFE dominance, notes accounted for 28% of early-stage deals in 2024 (down from 45% in 2020 but stable since 2022). Three reasons drive this:
- Investor governance: Notes can include board observation rights, information rights, and protective provisions. SAFEs typically can’t.
- Maturity pressure: The 18-24 month clock creates urgency to raise a priced round. Some founders want this accountability; others see it as unnecessary pressure.
- International comfort: Many non-US investors prefer familiar debt instruments over SAFEs, which remain less common outside Silicon Valley.
Finding the right investors for your stage and sector is crucial. Fundreef provides a searchable database of 10,000+ active VCs, angels, and funds—filtered by geography, check size, and industry focus. Stop sending blind emails and start connecting with investors actually writing checks in your space.
The kiss of death clause:
Every convertible note has a maturity date, but what happens if you reach it without raising a Series A? The standard note gives investors three options: demand repayment, extend the note, or convert at a shadow valuation (often the cap).
In practice, investors rarely demand repayment—it forces bankruptcy and wipes out their potential equity. But the possibility of repayment creates legal debt on your balance sheet, which can complicate future rounds or acquisitions. This is the main reason lawyers push back on notes.
Head-to-Head Comparison: Real Cost Analysis
Let’s run identical scenarios through both instruments using 2024 market terms.
Core Terms Comparison
| Feature | SAFE (Post-Money) | Convertible Note | Winner |
|---|---|---|---|
| Legal cost | $2K-5K | $5K-10K | SAFE |
| Closing speed | 1-2 weeks | 2-4 weeks | SAFE |
| Interest accrual | None | 4-8% annually | SAFE |
| Maturity date | None | 18-24 months | SAFE |
| Investor rights | Almost none | Information, pro-rata, sometimes board | Note |
| Dilution clarity | High (post-money) | Medium (depends on interest) | SAFE |
| International acceptance | Moderate | High | Note |
| Shadow Series scenario | Clean cap table | Debt liability | SAFE |
Financial Impact Comparison
Scenario: You raise $750K from angels, then do a $5M Series A twelve months later at a $20M pre-money valuation.
| Term Structure | SAFE Ownership | Note Ownership | Difference |
|---|---|---|---|
| $8M cap, 20% discount | 4.88% | 5.12% | +0.24% to note (due to 6% interest) |
| $10M cap, no discount | 3.90% | 4.09% | +0.19% to note |
| $6M cap, 20% discount | 6.67% | 7.00% | +0.33% to note |
The interest accrual gives note investors roughly 0.2-0.35% extra ownership per year—about $100K-175K in value at a $50M exit. Not huge, but not nothing.
Hidden Cost Comparison
| Cost Type | SAFE | Convertible Note |
|---|---|---|
| Annual legal/admin | $0 | $500-1,500 (K-1s, interest tracking) |
| Extension negotiations | N/A | $5K-15K if you hit maturity |
| Balance sheet impact | Clean | Debt liability affects credit, M&A |
| Investor reporting | Optional | Often quarterly updates required |
| Pro-rata complications | Minimal | Must track conversion timing carefully |
The real cost difference isn’t the $3K in legal fees—it’s the administrative burden. One founder told me his convertible notes required quarterly investor calls he wasn’t ready to do. Another nearly killed an acquisition when the buyer’s lawyers flagged $2M in outstanding debt (convertible notes) on the balance sheet.
When SAFEs Win (And When They Don’t)
SAFEs dominate in these scenarios:
1. Pre-seed/accelerator rounds ($100K-1M) Speed matters more than sophistication. You’re raising from angels who’ve seen hundreds of SAFEs and can sign within days. Post-money SAFEs from Y Combinator or Founders Institute come as standard templates your lawyer barely needs to touch.
2. Rolling closes with multiple small checks SAFEs let you close $50K today, $75K next week, and $100K next month without coordinating everyone. Notes technically require all investors to sign the same terms simultaneously (though many ignore this).
3. International founders raising from US investors If you’re incorporated in Delaware but operating in Berlin or São Paulo, SAFEs avoid cross-border debt complications. Several countries restrict foreign debt but treat SAFEs as forward equity contracts.
4. When you want governance flexibility Maybe you’re not ready to give anyone board observation rights. Maybe you want to keep decision-making lean. SAFEs preserve total founder control until the priced round.
Where SAFEs create problems:
Strategic investors who want involvement: A corporate VC investing $500K usually wants quarterly updates and maybe a board observer seat. SAFEs don’t allow this without custom amendments (which defeats the “simple” advantage).
Very long runway scenarios: If you’re building a hardware company with a 3-4 year path to Series A, the lack of maturity date means SAFE investors could wait years for conversion. Some get uncomfortable with this ambiguity.
Conservative investors outside Silicon Valley: Angels in Texas, Florida, or the Midwest often prefer the familiar structure of a note. Fighting this preference costs you momentum.
The Convertible Note Comeback in 2025
Something interesting happened in late 2024: convertible notes started gaining ground again after years of decline. Three trends explain this.
1. The “bridge to profitability” round
With Series A timelines stretching to 24-36 months post-seed (per PitchBook 2024 data), more founders are raising bridge rounds at higher valuations. These $1-3M rounds often come from existing investors who want protective provisions and information rights—things SAFEs don’t provide.
Basecamp’s Jason Fried closed a $2.5M convertible note in mid-2024 specifically because investors wanted quarterly metrics updates. The note structure formalized this without requiring a full priced round.
2. Revenue-based financing hybrids
Several funds now offer convertible notes with optional cash repayment from revenues. Founders pay back 1.5-2x the principal from monthly revenues OR convert at Series A, whichever comes first. This hybrid works better as a note because the repayment option requires debt structure.
Lighter Capital and Clearco both shifted toward this model in 2024, accounting for roughly $400M in deployed capital.
3. International investor requirements
European and Asian investors increasingly demand board observation rights and pro-rata participation guarantees. While you can add these to a SAFE, it requires heavy customization. Notes include these terms naturally.
Tiger Global’s seed deals in Southeast Asia consistently use convertible notes because local lawyers understand debt instruments better than SAFEs, reducing legal fees for portfolio companies.
Term-by-Term Negotiation Guide
For SAFEs:
Valuation cap (most important term)
- Market median in 2024: $8M for pre-seed, $12M for seed
- Negotiate based on traction: $500K revenue = $10-15M cap, $2M revenue = $20-25M cap
- Multiple SAFEs at different caps create confusion—try to consolidate
Discount rate
- Standard: 20%
- Only matters if Series A price is higher than the cap (which should be your goal)
- Some investors want cap + discount; push back unless they’re anchor investors
Pro-rata rights
- Increasingly common in 2025, especially for lead investors
- Standard language: “right but not obligation to invest pro-rata share in next round”
- Be careful: pro-rata on uncapped SAFEs can surprise you when calculating Series A dilution
MFN clause
- Investor automatically gets best terms of any future SAFE in the same round
- Sounds fair, but prevents you from offering better terms to strategic angels later
- Counter-offer: MFN only applies to SAFEs closed within 90 days
For Convertible Notes:
Interest rate
- Market range: 4-8% (most common: 5-6%)
- Lower is better for founders, but don’t die on this hill—it’s usually <0.3% extra dilution
Maturity date
- Push for 24 months minimum (18 months is too short given current fundraising timelines)
- Include automatic 6-12 month extension if you’ve hit specific milestones
- Example: “Automatically extends 12 months if company achieves $1M ARR or raises $500K+”
Qualified financing threshold
- This determines what triggers automatic conversion
- Standard: $1M minimum raise in preferred stock
- Negotiate down to $500K if you think Series A might be smaller
Conversion mechanics at maturity
- Best case: converts at the cap valuation (no repayment option)
- Acceptable: investors choose between conversion at cap or 6-month extension
- Avoid: investors can demand repayment (this is rare but deal-killing)
Information rights
- Most notes include quarterly unaudited financials + annual audited
- Try to limit to annual only until Series A
- Reject monthly reporting unless the investor is leading and providing significant value
Red Flags and Deal-Breakers
For any instrument:
Multiple discount stacks: An investor wants a 20% discount on top of the valuation cap, calculated separately. This is double-dipping. Standard structure: they get the better of cap OR discount, not both applied sequentially.
Uncapped, undiscounted SAFEs: Also called “shadow equity,” this gives investors the same price as Series A with no reward for early risk. Only acceptable from strategic partners providing massive non-cash value (customers, distribution, etc.).
Custom legal terms: If an investor sends a 12-page “simple” SAFE with customized governance provisions, they’re trying to get priced-round rights without the accountability. Use standard Y Combinator or Founders Institute templates.
Repayment provisions in notes: Any note that seriously contemplates cash repayment is dangerous. The exception: revenue-based notes where repayment is the expected outcome and explicitly modeled.
Automatic conversion at fixed valuation: Some notes convert automatically at maturity at a predetermined valuation (often the cap) whether you’ve raised or not. This creates phantom equity on your cap table without new capital.
Specific to SAFEs:
Pre-money SAFEs after 2020: These create dilution confusion. If someone insists on pre-money, they don’t understand the instrument or they’re trying to confuse you.
Excessive pro-rata rights: A $25K angel investor demanding pro-rata rights in every future round is unreasonable. Set minimums: “Pro-rata available to investors of $100K+” or “Top 10 investors by dollar amount.”
Specific to notes:
Variable interest rates: Notes tied to prime rate or LIBOR are unnecessarily complex for startup financing. Use fixed rates.
Maturity dates under 18 months: You need time to hit milestones. Anything shorter creates artificial pressure and potential default scenarios.
Board seats before Series A: Convertible notes sometimes include “if not converted by maturity, investor gets board seat.” This is founder hostile—board composition should be determined at priced rounds.
Making Your Decision: A Framework
Choose a SAFE if:
- You’re raising <$1M in a pre-seed or seed round
- You’re closing multiple small checks over 2-4 months
- Your investors are experienced angels/VCs familiar with SAFEs
- You want to minimize legal costs and administrative burden
- You don’t need investor governance or reporting structure yet
- You’re confident you’ll raise a priced round within 18 months
Choose a Convertible Note if:
- You’re raising from strategic investors who want information rights
- Your investors are international or unfamiliar with SAFEs
- You want the maturity date as accountability/milestone
- You’re raising a bridge round from existing investors at a higher valuation
- You need to offer board observation rights to close a lead investor
- You’re comfortable with quarterly investor updates and reporting
The hybrid approach:
About 12% of seed rounds in 2024 used both instruments in the same round (per Carta data). Common structure:
- Lead investor(s) get a convertible note with information rights, pro-rata, and board observer seat
- Smaller angels get SAFEs with the same valuation cap and discount
This works when you need to give your lead the governance they require while keeping follow-on investors simple. Make sure both instruments convert on the same terms at Series A.
Run the math:
Before choosing, model your Series A dilution under both scenarios. Free tools:
- Carta’s dilution calculator (requires account)
- Cooley GO’s SAFE and note calculators (free, no account needed)
- AngelList’s valuation cap calculator
Plug in your raise amount, cap, discount, and expected Series A valuation. The difference in founder ownership is usually <1%, which means other factors (speed, investor preference, governance) should drive your decision.
Ready to start your fundraising journey? Fundreef connects you with active investors matching your startup’s stage, sector, and geography. Join 5,000+ founders already using our platform to accelerate their fundraising.
FAQ Section
Q: Can I convert a SAFE to a convertible note later? A: Not directly, but you can raise additional capital on a note while keeping existing SAFEs in place. The two instruments will convert simultaneously at your Series A. Just ensure they have the same valuation cap to avoid investor confusion.
Q: What happens to SAFE investors if I sell the company before raising a Series A? A: Most SAFEs include a change-of-control provision. Investors either get their money back (1x return) or convert to equity at the cap valuation and participate in the sale. Post-money SAFEs specify exact conversion math, while pre-money SAFEs require calculation. Always check your specific SAFE template.
Q: Do I need a lawyer to issue a SAFE? A: For standard Y Combinator template SAFEs with no modifications, many founders close without lawyers (though it’s not recommended). For customized SAFEs or any convertible note, absolutely hire a startup attorney. Budget $2-5K for SAFEs, $5-10K for notes. Orrick, Cooley, and Gunderson Dettmer all offer startup-friendly rates.
Q: Can I cap the total dilution from SAFEs? A: Not easily. SAFEs convert based on their cap or discount, regardless of how many you’ve issued. This is why it’s crucial to track cumulative SAFE totals. If you’ve raised $2M on SAFEs with an $8M cap, you’re giving away roughly 25% of your company (post-money math) before your Series A even starts.
Q: What’s a “side letter” and should I sign one? A: A side letter is a separate agreement giving specific investors extra rights beyond the SAFE or note terms—often pro-rata rights, information rights, or MFN status. Only sign these for strategic lead investors providing significant value. Never sign side letters giving better economic terms (lower cap, higher discount) without offering the same to all investors.
Q: How do I handle SAFEs from 2017 that still haven’t converted? A: Old pre-money SAFEs sitting for 5+ years create serious cap table issues. Options: (1) negotiate a conversion at current valuation, (2) buy out the investors at 1.5-2x their investment, or (3) let them convert at Series A but expect significant dilution. Always address zombie SAFEs before new fundraising—investors hate cap table surprises.
